Subject: Re: G. Lincoln
From: "Howard Krein" <[email-masked]>
To: "Shaw,Kenna R" <[email-masked]>
Cc: <[email-masked]>, <[email-masked]>, "Yung,W K Alfred" <[email-masked]>, <[email-masked]>, "Mills,Gordon B" <[email-masked]>
Date: Sat, 21 Mar 2015 04:20:07 +0000

Thank you for the update Kenna. Patrick just incase you didn't know we have used George Lincoln as an alias and would like to continue to use that for all lab work and communications.
Thank you all for you continued work and sensitivity.
Warmly,
Howard

Howard D. Krein MD, PhD
Assistant Professor
Div. of Facial Plastics and Reconstructive Surgery
Dept. of Otolaryngology/ Head and Surgery
Thomas Jefferson University
215-955-6760<tel:215-955-6760>

On Mar 20, 2015, at 10:47 PM, Shaw,Kenna R <[email-masked]<mailto:[email-masked]>> wrote:

Dear Dr. Soon Shiong,

The requests for tissue are underway.  We should have a formal update on the status of all samples to you by the first week in April.  Blood should arrive at NantOmics next week followed by the historical 2013 tissue and the tissue scheduled as part of surgery for next week.  As soon as we know whether we can harvest tissue for your assay, we will be in touch.  We have been working well with Kim to get all material and consents to you.

If you have any questions, please do let us know.

Kenna Shaw

Kenna R. Mills Shaw, Ph.D.
Executive Director
Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (IPCT)
1400 Holcombe Blvd. | FC12.2002|Houston, TX 77030
*  713.792-1873 office; 713-792-6670 main; 713-792-6671 fax

The information contained in this transmission contains privileged and confidential information. It is intended only for the use of the person named above. If you are not the intended recipient, you are hereby notified that any review, dissemination, distribution or duplication of this communication is strictly prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message.

CAUTION: Intended recipients should NOT use email communication for emergent or urgent health care matters.